United States · FDA National Drug Code directory
Xofigo
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50419-208_3d1f78f4-d3bd-4778-a610-7d0827dd66c4
- Product NDC
- 50419-208
- Form
- INJECTION
- Composition / generic term
- Radium Ra 223 dichloride
- Labeler
- Bayer HealthCare Pharmaceuticals Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20130520
- Source listing expiry
- 20271231
Source-listed ingredients
- RADIUM RA-223 DICHLORIDE — 30 uCi/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 6 mL in 1 VIAL, SINGLE-DOSE (50419-208-01) · 50419-208-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →